Global Polymerase Chain Reaction Technologies Market By Technology (Real-Time, Digital, Traditional), Application (Forensics, Research, Clinical), Product (Instruments, Reagents & Consumables, Software, Services), End User (Biotech & Pharma Companies, Diagnostic Centers & Hospitals, Academic & Research Institutions)

Analysis of Market Size & Trends

Polymerase Chain Reaction Technologies Market size is expected to reach $11.5 billion by 2024, rising at a market growth of 6.2% CAGR during the forecast period. Polymerase chain reaction technology devices are medical devices that are primarily used to generate thousands to millions of copies of a piece of deoxyribonucleic acid (DNA). These devices are majorly used in different life science fields such as genetics, molecular biology research, biotechnology, drug discovery, and clinical diagnostics. Additionally, the technology is also used in identifying criminals and child identity in various forensics departments.

Further, the device is also being used in diagnosing disease such as middle ear infections, tuberculosis, AIDS, and Lyme diseases. Growing geriatric population, growing prevalence of infectious diseases, rapidly growing diagnostic centers and hospitals, technological advancements, and growing awareness and acceptance of personalized medicine are the factors that drive the polymerase chain reaction technologies market. Nevertheless, growing non-validated home-brew tests and reimbursement issues are the factors that limit the growth of the market. Also, accuracy and timely results for RT-PCR would further add to the challenges to the polymerase chain reaction technologies growth. Less tedious processes open avenues for the PCR market. Additionally, increasing funding towards research and development activities and large untapped markets in developing regions would further add to the market opportunities during the forecast period.

Global Polymerase Chain Reaction Technologies Market Size

Click Here For Free Insights

Based on Technology, the Polymerase Chain Reaction Technologies Market Size is segmented into Real Time PCR, Digital PCR and Traditional PCR. Based on Application, the market is segmented into Forensics, Research and Clinical. Based on Product, the market is segmented into Instruments, Reagents & consumables, Software and Services. Based on End user, the market is segmented into Biotech & Pharma Company, Diagnostics Centers & Hospitals and Academic & Research Institutions. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

Global Polymerase Chain Reaction Technologies Market Share

The Polymerase Chain Reaction Technologies Market Analysis report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, BioMérieux, Bio-Rad Laboratories, Inc., Hoffmann-La Roche Ltd., Fluidigm Corporation, LGC Limited, Qiagen NV, SYGNIS Pharma AG, Takara Bio, Inc., and Thermo Fisher Scientific.

Scope of the Polymerase Chain Reaction Technologies Market Analysis

Market Segmentation:

By Technology

• Real-time PCR
• Digital PCR
• Traditional PCR

By Application

• Forensics
• Research
• Clinical

By Product

• Instruments
• Reagents & Consumables
• Software
• Services

By End User

• Biotech & Pharma Company
• Diagnostics Centers & Hospitals
• Academic & Research Institutions

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Agilent Technologies
• BioMérieux
• Bio-Rad Laboratories, Inc.
• Hoffmann-La Roche Ltd
• Fluidigm Corporation
• LGC Limited
• Qiagen NV
• SYGNIS Pharma AG
• Takara Bio, Inc.
• Thermo Fisher Scientific